These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37846939)

  • 1. Ruthenium-Based Photoactivated Chemotherapy.
    Bonnet S
    J Am Chem Soc; 2023 Nov; 145(43):23397-23415. PubMed ID: 37846939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.
    Chen Y; Bai L; Zhang P; Zhao H; Zhou Q
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypyridyl Ruthenium(II) Complexes with Red-Shifted Absorption: New Promises in Photodynamic Therapy.
    Banerjee S
    Chembiochem; 2021 Jul; 22(14):2407-2409. PubMed ID: 33710756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
    Jakubaszek M; Goud B; Ferrari S; Gasser G
    Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strained ruthenium complexes are potent light-activated anticancer agents.
    Howerton BS; Heidary DK; Glazer EC
    J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
    Mo J; Mai Le NP; Priefer R
    Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
    McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
    Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
    Lee SY; Kim CY; Nam TG
    Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Ru-anthraquinone dyad with triple functions of PACT, photoredox catalysis and PDT upon red light irradiation.
    Zhang C; Guo X; Da X; Wang Z; Wang X; Zhou Q
    Dalton Trans; 2021 Aug; 50(31):10845-10852. PubMed ID: 34296720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium(II) polypyridyl complexes as emerging photosensitisers for antibacterial photodynamic therapy.
    Ng XY; Fong KW; Kiew LV; Chung PY; Liew YK; Delsuc N; Zulkefeli M; Low ML
    J Inorg Biochem; 2024 Jan; 250():112425. PubMed ID: 37977020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
    Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
    Heinemann F; Karges J; Gasser G
    Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Ruthenium Nanophotocages with Red or Near-Infrared Light-Responsiveness.
    Zhang Z; He M; Wang R; Fan J; Peng X; Sun W
    Chembiochem; 2023 Dec; 24(24):e202300606. PubMed ID: 37837285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Exploration of the Mechanism of Action of a Sorafenib-Containing Ruthenium Complex as an Anticancer Agent for Photoactivated Chemotherapy.
    Barretta P; Ponte F; Escudero D; Mazzone G
    Molecules; 2024 Sep; 29(18):. PubMed ID: 39339293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA.
    Chen Y; Lei W; Jiang G; Hou Y; Li C; Zhang B; Zhou Q; Wang X
    Dalton Trans; 2014 Nov; 43(41):15375-84. PubMed ID: 25188424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.
    Cuello-Garibo JA; Meijer MS; Bonnet S
    Chem Commun (Camb); 2017 Jun; 53(50):6768-6771. PubMed ID: 28597879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
    Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy.
    Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ
    Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.
    Monro S; Colón KL; Yin H; Roque J; Konda P; Gujar S; Thummel RP; Lilge L; Cameron CG; McFarland SA
    Chem Rev; 2019 Jan; 119(2):797-828. PubMed ID: 30295467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.